Kimelman & Baird, LLC
- SEC CIK
- 0001318103
- Latest filing
- Aug 18, 2026
ABT holding history
Abbott Laboratories in every 13F filed by Kimelman & Baird, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q2 2026 holdings
- Shares (Q2 2026)
- 23,506
- Value
- $2.13M
- % of portfolio
- 0.2%
- Quarters held
- 10
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 23,506 | $2.13M | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2026 | 23,506 | $2.41M | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2025 | 23,506 | $2.95M | 0.2% | −133−0.6% | Reduced | Holders |
| Q3 2025 | 23,639 | $3.17M | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2025 | 23,639 | $3.22M | 0.3% | 00.0% | Unchanged | Holders |
| Q1 2025 | 23,639 | $3.14M | 0.3% | −6,300−21.0% | Reduced | Holders |
| Q4 2024 | 29,939 | $3.39M | 0.3% | 00.0% | Unchanged | Holders |
| Q3 2024 | 29,939 | $3.41M | 0.3% | 00.0% | Unchanged | Holders |
| Q2 2024 | 29,939 | $3.11M | 0.3% | – | No prior filing | Holders |
| Q3 2021 | – | – | – | – | Not filed | Holders |
| Q2 2021 | 20,300 | $2.35M | 0.2% | – | No prior filing | Holders |